TOPICAL TREATMENT FOR ANIMALS

Information

  • Patent Application
  • 20240000881
  • Publication Number
    20240000881
  • Date Filed
    May 18, 2023
    11 months ago
  • Date Published
    January 04, 2024
    4 months ago
Abstract
A topical formulation and method of using the formulation on animals including dogs is disclosed. The formulation is used to facilitate the healing of cuts, scrapes, abrasions, and other conditions often experienced by animals. A main ingredient of the formulation is sulfur in a high concentration.
Description
NOTICE OF COPYRIGHTS AND TRADE DRESS

A portion of the disclosure of this patent document contains material which is subject to copyright protection. This patent document may show and/or describe matter which is or may become trade dress of the owner. The copyright and trade dress owner has no objection to the facsimile reproduction by anyone of the patent disclosure as it appears in the Patent and Trademark Office patent files or records, but otherwise reserves all copyright and trade dress rights whatsoever.


SEQUENCE LISTING

The instant application contains a Sequence Listing which has been submitted in XML format via EFS-Web and is hereby incorporated by reference in its entirety. The XML copy created Sep. 8, 2023 is named TOPICAL-TREATMENT-FOR-ANIMALS-1694204749621 and is 22 KB in size.


BACKGROUND
Field

This disclosure relates to topical skin creams for use by animals such as domestic animals, farm animals, or wild animals.





DESCRIPTION OF THE DRAWINGS


FIG. 1 is a molecular diagram of Acemannan



FIG. 2 is a molecular diagram of Veracylglucan A



FIG. 3. Is a molecular diagram of Veracylglucan B



FIG. 4. is a molecular diagram of Veracylglucan C



FIG. 5. is a molecular diagram of Sulfur (S8)



FIG. 6. is a different angle representation of the molecular diagram of Sulfur (S8)





DETAILED DESCRIPTION

Today there exist many ointments, creams, gels and products for use with animals suffering from various skin ailments. Skin ailments in animals may be caused by a number of skin ailment vectors such as bacteria, fungi, viral infections, dirt, allergic reactions, toxins, and other harmful substances. Worse yet, these skin ailment vectors may be organic or inorganic matter. A plethora of nonprescription treatments exist, but unfortunately, most do not work and are meant for owners of pets to have peace of mind rather than actually relieve pain in an animal. There exist many prescription medications that can clear ailments. However, some of these prescription medications don't work, require a visit to a veterinarian to use, or worse yet, are not dosed properly by the attending veterinarian.


It would be beneficial if there were a simple formula that can treat a majority of skin ailments in various animals. The present disclosure discloses such a treatment. To date there are many products on the market for treating pet skin problems including hot spots but none of them are effective. When owners use the other products on the market, their pets have little to no relief from the symptoms and if there is relief, it does not last long. There is a lack of a substance having minimal ingredients (less than 10) that together, clear up persistent skin issues like hot spots, mange and open wounds.


The present disclosure relates to a topical ointment that is applied daily to an animal's affected area and is used to treat hot spots, mange, sores, open wounds and other related skin ailments.


The present treatment works especially well in cattle, horses, dogs, and other mammals. It can also work in non-mammals such as reptiles and fish. In one embodiment Topical Animal Cream (TPA) is composed of combining Sulfur, Aloe vera pulp, and petroleum jelly in various forms and proportions.


Sulfur is a chemical element with the symbol S and atomic number 16. It is abundant, multivalent, and nonmetallic. Under normal conditions, sulfur atoms form cyclic octatomic molecules with a chemical formula S8, as can be seen in figures five and six. Elemental sulfur is a bright yellow, crystalline solid at room temperature. Sulfur belongs to a nonmetallic chemical element (pure product: yellow crystalline solid) under the symbol S. It can actively react with many other elements. It exists in various kinds of forms and compound such as sulfide and sulfate minerals which can be found everywhere around the universe and earth. It is also a key element for all life as the major component of amino acids, vitamins and many other cofactors. Sulfur when mixed with other chemicals and when reacting with chemicals on the surface of a dog also has many antimicrobial and antipathogenic properties.


Sulfur may refer to pure elemental sulfur (S8), or sulfur coming in another form, but associated with other atoms. sulfur is often found bound to other atoms to make compounds such as Na2S8, SO2, SO3, H2SO3, H2S2O; Na2SO4, SOCl2, S4N4, P4S10P4S3. Additionally, different families of sulfur compounds may be utilized such as organosulfur compounds which include, Allicin, (R)-cysteine, Methionine, Diphenyl disulfide, Perfluorooctanesulfonic acid, Dibenzothiophene, and even Penicillin. Other families of organic sulfur compounds that may be used include Thiols, Thioethers, Sulfonium ions. Sulfoxides and sulfones, and Sulfonic acids.


Other forms of sulfur that may be used include Sulfur Colloidal, Azufre10, and regular commercially available sulfur cream. sulfur may also come in the form of common products such as, Liquimat, Sastid Soap, Sulfoam Sulfo-Lo, Sulmasque, Sulpho-Lac, Sul-Ray Aloe vera Acne, Thylox Acne, Treatment, Zapzyt Cleansingcream.


Sulfur has found its way into certain cosmetic products. A concentration of above 25% in any product be it pharmaceutical or cosmetic is very uncommon. Some sulfur is found in Acne creams, but the concentration is usually around 5% and not more than 10%. The concentrations listed are by volume or by weight. The reason the concentration of sulfur in other cosmetics and other pharmaceutical products is so low is multifold. First, others in the art have not appreciated that sulfur itself has many antibacterial, anti-inflammatory, and wound healing affects. Generally, when people make creams using Aloe vera, sulfur is never included, and inventors focus on the healing properties of Aloe vera antibacterial, anti-inflammatory, and enhanced healing effects of Aloe vera. However other inventors fail to appreciate that not only does Sulfur itself have healing effects, but it may actually facilitate the healing effects of Aloe vera derivative.


The next reason inventors have failed to identify a high concentration of sulfur as effective for treatments is because sulfur may exude a foul odor in high enough concentration. Research has indicated that sulfur and sulfur containing compounds when in high enough concentration may score very highly when measured by an olfactometer [Kasper et al, 2008]. Consumers have also reported that Sulfur has a foul odor when present in high enough concentrations. However, when mixed with TPA the foul odor is greatly reduced if not managed to levels that are undetectable by animals or the human nose. This is because Odorant (or the S8) does not necessarily chemically bond with hydrocarbon polymers found in TPA, but the bonds of the hydrocarbon polymers themselves may prevent Odorant S8 from actually becoming airborne and stimulating an organisms sensory neurons to detect the foul odor of sulfur. The reduction in foul odor is due to the interaction between carbon-carbon and carbon hydrogen bonds with sulfur atoms. Although not a traditional chemical bonding interaction, the bonds between the carbon-carbon and carbon-hydrogen actually prevent sulfur atoms from leaving the complex of TPA.


Third, when cosmetic and other pharmaceutical products have used higher concentrations of sulfur, the sulfur used is not S8, but actually other sulfur containing compounds such as Na2S8, SO2, SO3, H2SO3, H2S2O7, Na2SO4, SOCl2, S4N4. Though such products may be considered to contain “sulfur” because the element sulfur is present, this naming is actually a misnomer. The sulfur in the above compounds has electrons either shared or given up to other atoms, which makes it harder for the sulfur to react with other elements. When sulfur is bound to itself in the S8 form, the individual sulfur atoms can interact with other molecules which have an effect on reducing inflammation, promoting epithelial growth, reducing soars, and healing wounds.



Aloe vera is a perennial plant of the Xanthorrhoeaceae family. It is also placed by most sources in the Liliaceae family although it has been designated its own family, known as Aloeaceae. Aloe vera has succulent leaves and is widely cultivated around the world. Aloe gel consists primarily of water (>98%) and polysaccharides such as pectin, cellulose, hemicellulose, glucomannan, acemannan, and mannose derivatives. Aloe vera also contains potentially active constituents, such as vitamins, enzymes (especially amylase), minerals, sugars, lignin, saponins, salicylic acid, and amino acid.


In some instances, if Aloe gel is used the other 2% of the Aloe gel constituents that are not the actual Aloe gel must be removed for 100% pure Aloe gel. In other instances, Aloe gel that is up to our at least 80% Aloe gel may be used.


The Aloe leaf can be divided into two major parts, namely the outer green rind, including the vascular bundles, and the inner colorless parenchyma containing the aloe gel. Description of the inner central part of the aloe leaf may sometimes be confusing, due to the different terms that are used interchangeably such as inner pulp, mucilage tissue, mucilaginous gel, mucilaginous jelly, inner gel and leaf parenchyma tissue. Sometimes, the term “pulp” or “parenchyma tissue” refers to the intact fleshy inner part of the leaf including the cell walls and organelles. “Gel” or “mucilage” sometimes refers to the viscous clear liquid within the parenchyma cells. Sometimes the liquid may appear yellow.


The three structural components of the Aloe vera pulp are the cell walls, the degenerated organelles and the viscous liquid contained within the cells. These three components of the inner leaf pulp have been shown to be distinctive from each other both in terms of morphology and sugar composition as shown in figure below. The raw pulp of A. vera contains approximately 98.5% water, while the mucilage or gel consists of about 99.5% water. The remaining 0.5-1% solid material consists of a range of compounds including water-soluble and fat-soluble vitamins, minerals, enzymes, polysaccharides, phenolic compounds and organic acids.



Aloe vera pulp may be obtained through commercial means or grinding and straining the Aloe vera plant. In other forms, Aloe from the plant may be combined with plant material (including Aloe vera plant) and the pulp derived from there. Additionally, at times Aloe vera pulp may be combined with other chemicals including alcohols, stabilizers, surfactants, salts, acids, sugars, enzymes, impurities, and other chemicals not naturally occurring or naturally occurring to the Aloe vera plant. The inclusion of these additional chemicals into the TPA, will not affect its efficacy, however in certain instances it may be favorable not to include these additional chemicals. Additionally, there are many Aloe vera pulp beverages that may also be combined and work to form TPA. Additionally, sometimes it is best to keep impurities below 5% by weight of the final solution. Sometimes it is best to have no more than 1 g of impurities.


In some instances, Aloe vera derivative, Aloe vera constituent, and Aloe vera may be used interchangeably. In other instances, Aloe vera may refer to Aloe vera gel. Aloe vera may also refer to Aloe vera constituent. Aloe vera derivatives and Aloe vera itself may be used. One Aloe vera derivative is Acemannan (C66H10NO49). Acemannan has an IUPAC name of Methyl 3-O-acetyl-4-O-methyl-α-D-mannopyranosyl-(1->4)-3-O-acetyl-α-D-mannopyranosyl-(1->4)-3-O-acetyl-α-D-mannopyranuronosyl-(1->4)-3-O-acetyl-α-D-mannopyranosyl-(1->4)-2-acetamido-2-deoxy-α-D-mannopyranosyl-(1->4)-3-O-acetyl-α-D-mannopyranosyl-(1->4)-3-O-acetyl-α-D-mannopyranosyl-(1->4)-3-O-acetyl-α-D-mannopyranoside. Acemannan may sometimes replace Aloe vera entirely when making TPA. In other instances, a certain dry weight percentage of Acemannan must be found in the final product of TPA. In one embodiment 0.001-1% Acemannan by dry weight must be found in the final TPA for the TPA to be effective.


Veracylglucan is another Aloe derivative found in Aloe vera. One particularly potent form for TPA is Veracylglucan C (C56H82O51). Veracylglucan C has an IUPAC name of (3S)-4-{[(2R,3S,4R,5R,6R)-3-{[(2R,3R,4R,5S,6R)-6-({[(2S)-3-carboxy-2-hydroxypropanoyl]oxy}methyl)-3,4-dihydroxy-5-{[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-6-{[(2R,3S,4R,5R,6R)-2-({[(2S)-3-carboxy-2-hydroxypropanoyl]oxy}methyl)-6-{[(2R,3S,4R,5R,6R)-2-({[(2S)-3-carboxy-2-hydroxypropanoyl]oxy}methyl)-6-{[(2R,3S,4R,5R)-2-({[(2S)-3-carboxy-2-hydroxypropanoyl]oxy}methyl)-4,5,6-trihydroxyoxan-3-yl]oxy}-4,5-dihydroxyoxan-3-yl]oxy}-4,5-dihydroxyoxan-3-yl]oxy}-4,5-dihydroxyoxan-2-yl]methoxy}-3-hydroxy-4-oxobutanoic acid. Veracylglucan is found in many Aloe vera plants. Some plant Aloe plants contain Veracylglucan C in less concentration when compared to Veracylglucan A and B. When Veracylglucan C is at a lower concentration, or a lower concentration when compared to Veracylglucan A and B, better wound healing results may be obtained.


Veracylglucan may sometimes replace Aloe vera entirely when making TPA. In other instances, a certain dry weight percentage of Veracylglucan must be found in the final product of TPA. In one embodiment 0.001-1% Veracylglucan by dry weight must be found in the final TPA for the TPA to be effective. Other researchers have indicated that Veracylglucan A and Veracylglucan B have different or even better healing results when used in other jells or on their own. In the experience of the inventors this is false. When using an Aloe vera derivative with a higher proportion of Veracylglucan C better healing results have been obtained. More so, when Veracylglucan A and Veracylglucan B are removed from TPA entirely, to only leave Veracylglucan C in the final TPA better results are obtained. In one embodiment 0.001-1.5% Veracylglucan B by dry weight must be found in the final TPA for the TPA to be effective.


The Enzyme amylase is present in every Aloe vera producing plant. Aloe vera containing high levels of amylase has been found to provide better wound healing properties for TPA. Interestingly enough, the amylase may be denatured and still make the TPA effective. The following protein sequences for amylase are effective when added to TPA.










Sequence ID 1



MPVDHGAHDALDDLLAGRHPDPFHILGPHADGPRSWVRVLVPNAEQVTVLLGAKDEE






WPLTHVRHGMYSGLVDGLAPGQPTAYRLRIKWPTGEQITEDPYAFSALLGDLDLHLISE





GRHEYLADCLGSHVMDVEGVRGVRFAVWAPNARRVSVVGDFNSWDGRRHPMRLRHS





AGVWEIFIPRLQAGTRYKYEIAGPEGQLLPLKADPLARQTEAPPATASIVPDPTPYTWTD





DDWMATRAARQAQDAPITVYEVHAGSWLPRDGEDDGECVWRRLATRLVPYARDLGF





THLELMPIMEHPFGGSWGYQPLGVFAPTARYGTPRDFAAFVDACHAAGLAVILDWVPA





HFPTDTHGLSHFDGTALYEYQDPREGFHPDWNTLIYNLGRTEVHNFMVASALEWVRRY





HIDGLRVDAVASMLYRDYSRAAGEWIPNRYGGRENLEAVDFLRDMNATVHRLCPGAIT





VAEESTAWPGVSARTEDGGLGFSYKWNMGWMHDTLRYMHNDPVHRRYHHNDMTFG





MVYAYSERFILPLSHDEVVHGKGSLLNKMPGDRWQRHANLRAYFGFMWGHPGKKLLF





MGGEIAQEREWNHDASLDWGALDDGLHRGVQKLVRDLNHVYAELPALHRHDHDASG





FEWLIGDDYANSVYAFVRRDGDALALVVCNFTPVPRDGYRIGVPRAGRWRERINTDAG





DYGGSGMGNSGGRHTEAVAAHGREQSLVLTLPPLATLIFQFEG





Sequence ID 2



MRIYYVHPLHVGSLSGDSFSHWQARCARIKSLGFDTLMTAPLWAPDPAGNPYVPDDPD






RLHPALGDMDLAAAMTALSRLCGEHGLALMIDLPLEKVAIDGAAARAHPHWYEDAGG





DALLDPRRPWEDRHALPLRREHGRAPAGFVDHWIERLGLWVENGVAGFRCEGLAQLA





PADWRDLIQGVRAVRPDCRWLAWTPGVAPWDVAPLAGVGFDGVFSSFPWWDYRAEW





LLEETDRLRAIAPVIAPVEAPYAKRVASWRSDPAGRYRNAARAVWTAAVVGDGVLVP





MGFEDAATHALERDGSGVREDPQGDPGLHIDIGRANQWLARTASARGPLHSLQGPHTG





VTALFRGDGAATPAAGAGRGSARLIVLNPSDDVAASPDWDALRARLPDGYGRLDQWD





ADRPAQDLPTTLAPGDMLRLGASRLPPVTVPASDDTRLGVTAAMRQPRLAIEHVTPAV





DDGAFPIKRIAGETITVEADVFCDGHEYIAVALLWRAADDKEWQRVPMTPLGNDRWTA





SFAPARIGRHYYAVQGWDDAWTTFRDGLEKKYRAGVDIALETAEGRGLVQEALERLPD





TAETSAAALRQVLRVLGAAPAEKPRRDRKKSAGEASPPRFPSPTPDQVAALLDAATARA





MREADDRRFETTSAIYPVTVDRPAAIFSSWYEIFPRSQSGDPRRHGTFDDVIATLPRVRA





MGFDTLYFPPIHPIGARNRKGRNNSLQAGPDDPGSPYAIGSEDGGHDALHPQLGTLDDF





RRLVAAARAHGLELALDFAIQCSPDHPWLKAHPEWFDWRPDGSLKYAENPPKKYEDIV





NVDFYGAKPGASRQAPLWRALRDVVLFWVAQGVRVFRVDNPHTKPLPFWEWMIGDV





QGRHPDVLFLSEAFTRPKMMYRLAKVGFSQSYTYFTWRETKQEFTEYLTELTQGPPADF





FRPHFFVNTPDINPRFLQQSGRGGFLIRAALAATLSGLWGVYNGFELCEASAVPGKEEYL





DSEKYEIRAWDHERPGNIVREITRLNAIRRANPALHTHLGVRWHTAWDDQVLFFSKSTP





QRDNVLLVAISLDPHHPRDVVLEIPMWEFGLPDDGPLQAEDLIDGNRMVWRGKQQGVH





LHPDQPYRIWRVTPA





Sequence ID 3



MTASVPAVSYSHGAVRQAGGRTRFRLWAPNANDGVVLEIAGHEPLPMRVVADGYYEI






DADCEPGARYRYRVAPDLAVPDPASRLQAGDVHDDSVVVDGGDAYAWRHPDWRGRP





WTETVLYEVHPGLAGGYAGIEQRLPELAALGITAIELMPIADFPGPRNWGYDGVLPYAP





DRAYGDPDELRRLIDTAHGLGMMVFLDVVYNHFGPDGNYLNAYAADFFRQDLQTPWG





AAIDFRRPQVRRYFAENALYWLAEYRFDGLRLDAVHAIRDVGWLEEMAAFVRAHIDPG





RHVHLVLENDDNQVHPLLHGYQAQWNDDAHHVLHHLLTGESEGYYEDYVEQPAQRL





ARALTEGFVYQGQPSRHRGGQRRGERSDLLPPTAFVFFLQNHDQTGNRALGERLGPLLR





DARILKAATALQLLTPQIPLIFMGEERGATTPFLYFTSHADPQLATAVRDGRRKEFQHFR





AFANPAMRERIPDPNDPATYANANPFTGEPDADTLATYTELLAVRRREIVPRLQGAHAL





GAHVLGLRAVVAQWRMGDGATLTLYANLGGVDLRPDWLQVDLADQAVVYESETGA





GAALHEGLLWRGCTIALLQAPVAGARMTTDTKEYP.





Sequence ID 4



MARQATGRAPAPRPAVPHLASDARLNAQPGRVPRPAQRQEDNGMSDNHVNSPNRDDP






LWYKDAVIYQLHVKSFFDANNDGVGDFAGLVEKLDYIASLGVNTIWLLPFYPSPRRDD





GYDIAEYRGVHPDYGTLAGVRKLIKAAHARGLRVITELVVNHTSDQHPWFQRARRAKP





GSAARNYYVWSDNDQAYAGTRIIFLDTEKSNWTWDPVAGAYFWHRFYSHQPDLNYDN





PQVLKEVIGVMRFWLDLGVDGLRLDAVPYLVEREGTNNENLPETHAVLKKIRAQLDAE





YPGRMLLAEANQWPEDAQEYFGQGDECHMSFHFPLMPRMYMAIAREDRFPITDIMRQT





PDIPETCQWAIFLRNHDELTLEMVTSNERDYLWNTYAADRRARINLGIRRRLAPLMERD





RRRIELMNSLLLSMPGTPVIYYGDELGMGDNIHLGDRDGVRTPMQWSPDRNGGFSRAD





PERLPLPPLMGPLYGYEAVNVEAQQRDPHSLLNWSRRMLATRAKTQAFGRGTLRFLFP





GNRNILAYLREYEATTILCVANLSRASQPVELDLSSLAGRVPVELLGGTPFPAIGELTYLL





TLPPYGFYWFDLSASASPPEWHATHPERMPEYYTLVLRGRTGYELTEGAVRSLREDVLP





LYLSRQRWYPKDRKVKMAQAAYAAQLPGADHECFIAEIQVDFDGKPARFLLPAALIWD





ETLPPMAQQYALARVRRAAEMGYLTDAFTLPSFIHALVRGLRERTEIPVPRAHPPAVLRF





RGEPTLDKIELPPDAEVQWFTGEQSNSSVTLGGIMMLKLLRRIVPGVHPEAEMTRRLTEV





GYANGAPLLGEIQRIDEDGTPHTLALMHQMITNQGDAWTWTLNYLKRTLEAAALTAES





AEDYDEDLLGYINFAHTMGKRLGELHAALSLPTDDAAFKPHRATRHDAERRAKAVIAM





LDQGLDTLKANMGRLDAAHAETAAWLAEHRDALVEVVRDLAANEEDTLHIRIHGDFH





LGQVLAAQGDAYLIDFEGEPARTLEERRAKTSALRDVAGLLRSFDYAAATLADGTGKG





KGKAEETGEAQIAEQQLRTRRQDLIERFRVTAGESFLAGYREVAHTTEHPWITPEVEAPL





IDLALIEKAAYEVRYEAAHRPDWVGIPLAGLASLAARLLSDGSAASSHP.





Sequence ID 5



MPNQPRITEGSPFPLGATLDDDGVNFALFSAHATKVELCLFDELGEQETERIVLPEFTDEI






WHVHVAGLNAGTVYGYRVHGPYEPENGHRFNPNKLLLDPYAKAYVGELKWDPAVFG





YPIGDEQADLGFDERDSAAFVPKCRVVDQRFTWTHATRVRVPWERTIFYETHVRGYTM





RHPAVPEALRGSFAGLARDAVIDHIKSLGVTSVELLPIHAFVNDSHLLEQGLTNYWGYN





TIGFFAPDPRYFSQVPGAITELKQMIDRFHEAGLEIILDVVYNHTAEGSELGPTLSFRGIDN





ASYYRLLPDQKRYYINDTGTGNTLNLSHPRVLQMVMDSLRYWVTEMKVDGFRFDLATI





LAREPDGFDYNSGFLKACRQDPILSSVKLIAEPWDCGPGGYQVGNFPPGWAEWNDRYR





DTVRAFWKGDEGMAPELAGRITGSGGDFNHGGRRPWASVNFLTAHDGYTLNDLVSYN





DKHNEANGEDNRDGHSDNRSWNCGAEGPTDDPDIRALRERQKRNMLATLLFSQGTPMI





VAGDEFGRTQQGNNNAYCQDNEISWVDWEINEDGAALIEFLRKLTTLRHTLPVLRRGRF





LTGDYDESMDVADVKWLSSSGEALTPEQWADTNMRCFGLIIDGRARATGIRRPASDAT





LLLIFNAYHDVVDFTLPEIPGNDRWTCLIDTNAPVRAELPQFASGDVYQVTGRSLLLFSL





QAKGPTQRVFDKLEEALTDEETPEPAREAAAIVKKSVKKEKPSK.





Sequence ID 6



MPNQPRITEGSPFPLGATLDDDGVNFALFSAHATKVELCLFDELGEQETERIVLPEFTDEI






WHVHVAGLNAGTVYGYRVHGPYEPENGHRFNPNKLLLDPYAKAYVGELKWDPAVFG





YPIGDEQADLGFDERDSAAFVPKCRVVDQRFTWTHATRVRVPWERTIFYETHVRGYTM





RHPAVPEALRGSFAGLARDAVIDHIKSLGVTSVELLPIHAFVNDSHLLEQGLTNYWGYN





TIGFFAPDPRYFSQVPGAITELKQMIDRFHEAGLEIILDVVYNHTAEGSELGPTLSFRGIDN





ASYYRLLPDQKRYYINDTGTGNTLNLSHPRVLQMVMDSLRYWVTEMKVDGFRFDLATI





LAREPDGFDYNSGFLKACRQDPILSSVKLIAEPWDCGPGGYQVGNFPPGWAEWNDRYR





DTVRAFWKGDEGMAPELAGRITGSGGDFNHGGRRPWASVNFLTAHDGYTLNDLVSYN





DKHNEANGEDNRDGHSDNRSWNCGAEGPTDDPDIRALRERQKRNMLATLLFSQGTPMI





VAGDEFGRTQQGNNNAYCQDNEISWVDWEINEDGAALIEFLRKLTTLRHTLPVLRRGRF





LTGDYDESMDVADVKWLSSSGEALTPEQWADTNMRCFGLIIDGRARATGIRRPASDAT





LLLIFNAYHDVVDFTLPEIPGNDRWTCLIDTNAPVRAELPQFASGDVYQVTGRSLLLFSL





QAKGPTQRVFDKIEEAITDEETPEPAREAAAIVKKSVKKEKPSK.






Dry Aloe vera or Aloe vera powder may also be used instead of regular gelatin Aloe vera or Aloe vera gel. There are multiple ways to make and types of dry Aloe vera. For Dry Aloe vera to work in any of the embodiments it must contains no more than 5% liquid water by weight. Note that when combined with other constituents such as hydrocarbons, sulfur, or petroleum jelly, liquid may be added to the entire TPA solution. This extra liquid however will not have an effect on the efficacy of the TPA.


In the experience of the inventors the best form of dried Aloe vera or Aloe vera powder may be produced by the following. First a specimen Aloe vera plant leaf is selected. So long as the leaf does not have blight or is rotten, all specimens will work. Next the plant should be washed in warm water. After washing the outer layer of the leaf (sometimes referred to as the rind) the rind should peeled away. The rind in most species of Aloe vera will be thick and green. Once the rind has been removed the specimen should be washed again. When washing a second time, a technician may notice yellow liquid exuding from the specimen. This yellow liquid contains many Aloe vera constituents, some of which sequester potassium when ingested. At this step a technician should be sure to wash their hands to prevent ingestion of the liquid for undesired effects.


The specimen may then be cut up into smaller pieces to make handling and desiccation easier. Whatever technique is used to cut up the specimen, the end specimen pieces should be of uniform size and shape to ensure even drying. Next the specimen pieces may be placed on trays or a flat surface and put into a desiccator. The desiccator should be turned to 135° F. degrees but not more than 200° F. In the experience of the inventors, 140° F. degrees works well.


Next the specimen should be desiccated for at least 12 hours. In the experience of the inventors no more than 50-56 hours has even been needed to desiccate a batch of cut up specimen. Desiccation times are mainly increased based on the liquid content of the specimens. Specimens with high liquid content will take longer to desiccate than specimens with smaller amounts. One the pieces have been fully dehydrated they need to be broken down further to create a fine powder. This may be accomplished with a mortar and pestle or conventional food processor. Once broken down into a fine powder, the dried Aloe vera may be dedicated further to reduce the liquid content of the final fine Aloe vera Powder product.


In some embodiments, the Aloe vera present in TPA may actually be formed from a 50%, 50% combination of wet Aloe vera gel and dried and rehydrated Aloe vera dust. A potential formulation for such formulation of TPA includes Aloe vera wherein the Aloe vera derivative may be selected from a group consisting of Aloe vera gel, Aloe vera powder Aloe vera extract, Veracylglucan (c56H82O51), Acemannan C66H101NO49; wherein the hydrocarbon polymer may be selected from the group consisting of petroleum jelly hydrogenated castor oil and beeswax. Another potential formulation includes 30%-33% by weight sulfur; 30%-33% by weight Aloe vera or Aloe vera derivative; 30-33% hydrocarbon polymer; at most 5% impurities. In other embodiments TPA may be made from ⅓ hydrocarbon polymer, ⅓ sulfur, ⅓ Aloe vera.


Another formulation includes the topical treatment above wherein the Aloe vera or Aloe vera derivative further comprises at least 30 micrograms of Veracylglucan, at least 10 micrograms of Acemannan, and 30 grams of Aloe vera plant extract. Another treatment includes the topical treatment above wherein the Aloe vera or Aloe vera derivative is obtained from a plant species within the Aloe family, the plant further comprising Aloe vera, Aloe viridiflora, Aloe excelsa, Aloe thraskii, and Aloe namibensis. Another treatment may include an impurities, the impurities further comprise amylase selected from the SEQUENCE ID 1, SEQUENCE ID 2, SEQUENCE ID 3, SEQUENCE ID 4, SEQUENCE ID 5, or SEQUENCE ID 6. The impurities may contain other chemicals or molecules besides amylase as well as amylase.


The specimen should then be dehydrated. To dehydrate the specimen, the specimen should be placed in a dry area and exposed to warmth for a week. If an oven is used, the oven should be heated to 200 degrees and the Aloe vera left there for 2-3 days. A desiccator may also be used to speed up the specimen drying process. Inserting the specimen into a dehydrating machine may comprise 135° F.-200° F. for six hours. It could also comprise inserting the specimen into a dehydrating machine may comprise 135° F.-200° F. for four.


The following Aloe vera derivatives have been found in and may be used in TPA. Aloe-emodin, aloetic-acid, anthranol, aloin A and B (or collectively known as barbaloin), isobarbaloin, emodin, ester of cinnamic acid Pure mannan, acetylated mannan, acetylated glucomannan, glucogalactomannan, galactan, galactogalacturan, arabinogalactan, galactoglucoarabinomannan, pectic substance, xylan, cellulose 8-C-glucosyl-(2′-O-cinnamoyl)-7-O-methylaloediol A, 8-C-glucosyl-(S)-aloesol, 8-C-glucosyl-7-O-methyl-(S)-aloesol, 8-C-glucosyl-7-O-methyl-aloediol, 8-C-glucosyl-noreugenin, isoaloeresin D, isorabaichromone, neoaloesin A, Alkaline phosphatase, amylase, carboxypeptidase, catalase, cyclooxidase, cyclooxygenase, lipase, oxidase, phosphoenolpyruvate carboxylase, superoxide dismutase, Calcium, chlorine, chromium, copper, iron, magnesium, manganese, potassium, phosphorous, sodium, zinc, Arachidonic acid, γ-linolenic acid, steroids (campestrol, cholesterol, β-sitosterol), triglicerides, triterpenoid, gibberillin, lignins, potassium sorbate, salicylic acid, uric acid.


The following amino acids, proteins, Saccharides and Vitamins have also been found in Aloe vera and may be used in TPA. Alanine, arginine, aspartic acid, glutamic acid, glycine, histidine, hydroxyproline, isoleucine, leucine, lysine, methionine, phenylalanine, proline, threonine, tyrosine, valine, Lectin, Mannose, glucose, L-rhamnose, aldopentose, B1, B2, B6, C, β-carotene, choline, folic acid, α-tocopherol.


Some Aloe vera pulp may contain trace amounts of calcium, copper, chromium, sodium, selenium, magnesium, potassium, manganese, zinc, and Vitamin B-12. Aloe vera pulp with these trace chemicals may be used and may actually be preferred.


In some instances Aloe vera with trace amounts of other constituents may actually be preferred to regular pure Aloe vera. For example Aloe vera with enriched Vitamin B-12 may actually facilitate healing better than a formulation made with regular Aloe vera. In some instances when Vitamin B-12 is enriched it should be enriched so the concentration of B-12 in the final TPA is between 0.006 micrograms and 6 micrograms per liter of TPA. In other instances, the concentration of TPA in should be 0.006-0.009 micrograms per liter of TPA.


In certain instances, Aloe vera pulp from individual strains of plants may be used. Strains may be selected based in part on their tendency to produce or overproduce certain chemicals. All strains fall within the Aloe genus of plants. These chemicals include, Anthraquinone, Aloin, Mannose, Acemannan, Aloe emodin, Emodin, Glucomannan, Anthrone, beta-Sitosterol, Chromone, Lupeol, Mannan, Streptozotocin, Arabinogalactan, Silver sulfadiazine, Sulfadiazine, Myristic acid, Allantoin, Polyethylene glycol, Alloxan. In other instances, a strain that under produces, or produces none of the above identified chemicals may also be selected for. For example a strain of Aloe vera that does not produce any Alloxan, or very little (0.001-10 μg of Alloxan per plant) of Alloxan may also be used for Aloe vera pulp.



Aloe vera sometimes refers to the specific genus and species of plants in the Aloe genus. Aloe vera derivatives, and plants that may also be referred to as Aloe vera, may also refer to plants within this genus including, Aloe aculeata, Aloe africana, Aloe albida, Aloe albiflora, Aloe arborescens, Aloe arenicola, Aloe argenticauda, Aloe bakeri, Aloe ballii, Aloe ballyi, Aloe brevifolia, Aloe broomii, Aloe buettneri, Aloe camperi, Aloe capitata, Aloe comosa, Aloe cooperi, Aloe corallina, Aloe dewinteri, Aloe erinacea, Aloe excelsa, Aloe ferox, Aloe forbesii, Aloe helenae, Aloe hereroensis, Aloe inermis, Aloe inyangensis, Aloe jawiyon, Aloe jucunda, Aloe khamiesensis, Aloe kilifiensis, Aloe maculata, Aloe marlothii, Aloe mubendiensis, Aloe namibensis, Aloe nyeriensis, Aloe pearsonii, Aloe peglerae, Aloe perfoliate, Aloe perryi, Aloe petricola, Aloe polyphylla, Aloe rauhii, Aloe reynoldsii, Aloe scobinifolia, Aloe sinkatana, Aloe squarrosa, Aloe striata, Aloe succotrina, Aloe suzannae, Aloe thraskii, Aloe vera, Aloe viridiflora, Aloe wildii.


In the experience of the inventor, the particular species Aloe vera, Aloe viridiflora, Aloe excelsa, Aloe thraskii, and Aloe namibensis produce an Aloe vera, Aloe vera derivative, impurities, or Aloe vera powder that not only enhances the healing of TPA, but also make all constituents of the TPA bind together more effectively than other plants within the Aloe genus.


Petroleum jelly is petrolatum, a hydrocarbon, C15H15N, (1,1,2-Trimethylbenzeindole) with a boiling point of 322° C. (610° F.) and a melting point between 70 and 80° C. (160 and 175° F.). It is flammable only when heated to liquid; then the fumes will light, not the liquid itself, so a wick material like leaves, bark, or small twigs is needed to ignite petroleum jelly. It is colorless or has a pale yellow color (when not highly distilled), translucent, and devoid of taste and smell when pure. It does not oxidize on exposure to the air and is not readily acted on by chemical reagents. It is insoluble in water. It is soluble in dichloromethane, chloroform, benzene, diethyl ether, carbon disulfide and oil of turpentine. Petroleum jelly may also be replaced with hydrogenated castor oil and/or beeswax. In some embodiments a Petroleum jelly, hydrogenated castor oil, and beeswax mix may be preferable to just petroleum jelly.


Petroleum jelly should only be used externally and not ingested. Although appropriate to put on a wound, even open soars, having Petroleum jelly enter the bloodstream and is not ideal. Additionally, petroleum jelly may be mixed with other hydrocarbons not conventionally found in Petroleum jelly such as glycerol, triglycerides, and esters. It should be appreciated that there are different brands of Petroleum jelly on the market, and that although the main chemical formula is the same, sometimes chemicals may be added to the petroleum jelly compositions. These additives do not usually have an effect on the efficacy of the TPA.


TPA is formed by mixing various versions of Sulfur, Aloe vera pulp, and petroleum jelly. In some forms of TPA, mixing sulfur powder, the pulp of the Aloe vera (fresh or freeze dried or Aloe vera powder) and petroleum jelly in equal parts yields effective TPA. Some forms of TPA are more effective if the Aloe vera pulp is fresh. Fresh can mean used within 24 hours or up to two weeks. If the Aloe vera is freeze dried or dehydrated then the mixture requires one part sulfur, one part petroleum jelly and ¼ part Aloe vera. The other part may be other chemicals or more sulfur and petroleum jelly. Once the Sulfur, Aloe vera pulp, and Petroleum jelly have been mixed, an ointment should be obtained.


Other effective formulations of TPA include 30% sulfur, 30% Aloe vera pulp, 30% Petroleum jelly, 10% water with additives. The other 10% may also constitute alcohol, glycerol, or cosmetic products. Additives to water include chemicals besides water. These chemicals may further include elemental chemicals such as carbon, or compounds. Other effective formulations include 25% Sulfur 25% Aloe vera pulp and 50% Petroleum jelly. 25% Sulfur 50% Aloe vera pulp and 25% Petroleum Jelly.


Other appropriate combinations include at least 30 grams of Aloe vera, at least 30 grams of petroleum jelly, and at least 30 grams of sulfur. At least 30 grams of Aloe vera, at least 30 grams of petroleum jelly, and at least 30 grams of sulfur and not more than one gram of impurities and/or other constituents. 30 grams of Aloe vera, at least 30 grams of petroleum jelly, and at least 30 grams of sulfur. 30 grams of Veracylglucan, 30 grams of petroleum jelly, 30 grams of solid powder form S8. 30 grams of Acemannan, 30 grams of petroleum jelly, and 30 grams of Sulfur. 30 milligrams of Veracylglucan, 10 milligrams of Acemannan, and 30 grams of Aloe vera plant extract, 30 grams of petroleum jelly, and 30 grams of sulfur.


The TPA may also be combined with other ointment agents that make the TPA appear to be more like ointment and increase its efficacy. Appropriate ointment agents include Squalane, Pentahydrosqualane, Liquid paraffin, mineral oil, Polyisobutene, Paraffin, and waxes. TPA may also come in non-ointment forms such as aerosol sprays, dusts, roll-on bars, or gels.


To effectively apply the TPA on an animal, an animal's affected area should be cleaned. An affected area is any party of the animal's skin or body that is irritated or infected. Types of irritations or infections include, ulcers, hot spots, red spots, infections, allergic reactions, cuts, bruises, welts, goiters, growths, or any part of the skin that is not maintaining normal homeostatic function. In other instances, an affected area can be a range of healthy and diseased tissue such as mumps and growths. If heavy mud or debris is present near a wound, the heavy mud and debris should be removed. Mud may be washed away with warm water, no soap. It should be noted that cleaning the area may disturb the animal's natural oils and secretions present in their skin and can further exasperate the skin issue. It should be noted that the cleaning should not disturb the animals' natural oils or secretions.


The TPA should then be applied to the wound site. This may be accomplished by rubbing the TPA into the animals wound and surrounding skin. In the experience of the inventors applying a bandage or wrapping material around the wound may prevent an animal from scratching. In most cases however, such wrapping is unneeded because the healing properties of TPA prevents the animal from continuing to attack the wound. The TPA may either be reapplied twice a day or every 4 hours as needed. In some instances, animal caretakers may wish to apply the TPA once a day for two weeks (fourteen days). In other instances, animal caretakers may wish to apply the TPA twice a day for fourteen days. Sometimes applying TPA 3-4 times a week for two weeks is sufficient.


TPA is especially effective against cuts. A cut is defined as a skin lesion in which the natural connectivity of epithelial tissue has been disturbed by an abrasion. TPA promotes epithelial cell growth. In the experience of the inventors, effective directions on how to use TPA include: cleaning the affected area if mud is present, and applying a thick layer of TPA to the affected area once a day for seven to twenty one days depending on the severity of the skin problem. If the animal is an indoor animal, you should cover the medicine with a t-shirt or bandage, so the medicine doesn't get everywhere. It is also important not to bathe the animal for a duration of the treatment. A slight bath may be permissible if the animal is muddy, but baths should be avoided for a duration of the treatment. Additionally, along with the cessation of medicated shampoos; over the counter shampoos and other topical treatments should be ceased during a duration of the treatment. TPA may be distributed in 4-84 oz containers and stored at 60° F.-86° F. (15° C.-30° C.). TPA is appropriate for most animals but is especially effective with dogs, cats, cattle, horses, and other livestock.


In other instances, if the affected area contains thick and long fur, the area should be sheared before the TPA is applied to ensure direct application on the affected area. Application of the TPA can occur in many ways. For one, the TPA may simply be slathered on the affected area. Other times a bandage or piece of cloth may be impregnated with the TPA, the bandage or piece of cloth introduced to the affected area. Treatments with cloth or band aids is often helpful to animals because the TPA may rub off and be less effective if not covered by something as the animal moves. Again, in certain instances, an animal's fur or epidural covering may need to be removed (for example shaved) for higher efficacy when the TPA is applied. In other instances, the TPA will retain its efficacy when applied directly on the fur, but to an affected area. At any rate the TPA should be thoroughly mixed, and the TPA generously applied to the animal's affected area of skin.


Before using TPA, it is important to check if an animal has already been prescribed or is already using medications. In most instances, if an animal is on a medication regime, the regime should be ceased before and during the use of TPA. In other instances, the use of TPA with a medicine regime need not be stopped. Animals on blood thinners or diagnosed with other heart medications might not be recommended for TPA. An animal's veterinarian or healthcare provider should be consulted if they have one of the above conditions before TPA is used.


TPA may also be combined with other chemicals to make the final composition more effective. For example the sulfur, Aloe, Petroleum jelly, may be combined with various other cosmetic products. For example TPA may be combined with Allantoin, Bacillus Ferment, Ceramide 3, Emu Oil, Euphorbia Cerifera (Candelilla) Wax, Glyceryl Behenate, Hydrogenated Castor Oil, Lysine HCl, Melaleuca Alternifolia (Tea Tree) Leaf Oil, Olea Europaea Fruit Oil, Phytosphingosine, Silver Citrate, Squalane, Tocopheryl Acetate, Tribehenin, Vegetable Oil.


A study was conducted to evaluate the effectiveness of TPA when applied to dogs. Dogs of various species, weights, sizes, health, and who may have at some point participated in other medical regimes (taking antibiotics, flea medication, mange medication). The study followed eleven test subjects as TPA was applied to various lacerations the subjects had. 90.9% of test subjects in the study experienced wound reduction. Wound reduction was characterized by handler reporting and photographic evidence of the wounds recorded before application of TPA and for various days after the application. Furthermore, percentage wound reduction was also measured within a margin of +−5% wound coverage. This means that a wound measured to have healed at 80% may be within 75%-85% healed.


63% reported healing of wounds within 90% within fourteen days of use. 27% reported 100% reduction in wound meaning full healing. Another 9% reported healing within a range of 70% while only 0% reported no healing at all. Furthermore, the data showed no correlation between, age and weight of dogs being sampled. The healing effects of TPA seem to be present regardless of dog weight or age.



















Wound
Wound Reduction


Test Subject
Weight (US

Reduction
Within +− 5%


No.
Pounds)
Age (months)
Reported
Completion



















1
60
36
Yes
 90%


2
13.22
132
Yes
 70%


3
65
36
Yes
100%


4
60
7
Yes
 90%


5
62
36
Yes
 90%


6
13
8
Yes
100%


7
45
48
Yes
 90%


8
15
7
Yes
 90%


9
20
60
Yes
 90%


10
15
12
Yes
 90%


11
10
144
Yes
100%









More information regarding this study can be found in the appendix of this patent application. This application filing contains an appendix providing for a more detailed explanation of the results. This appendix is entitled Appendix to the Specification K9 Skin Rescue Evidence and is hereby incorporated by reference. The evidence from this study show the remarkable effects of the present disclosure and are not a very unexpected result of mixing sulfur, with a hydrocarbon, Aloe vera and few (5% or less) impurities. Treating an animal with TPA is not as simple as slathering the TPA on an animal like other ineffective creams and gels. A method of applying a therapeutically effective amount of a topical treatment (TPA) for an animal wound on an animal in need thereof comprises various steps. An animal must be properly selected from an area it inhabits. This is more complicated than selecting a human subject because often times animals are herded or socialized together. This is important because diseases such as mange, and skin irritation may spread through a herd if a herd is kept together or may be spread faster in an indoor kennel for dogs compared to an outdoor one. The best form of selecting an individual animal from a group or herd is to verify that the individual animal has skin irritation or other conditions such as cuts. Dogs or animals that interact with the particular subject animal should also be examined to verify they either have or do not have a skin irritation or other condition.


Next, the subject or subjects selected should have their medical history reviewed. Diseases affecting blood pressure (but not including heart worms) should exclude an animal from treatment. However, in some instances an animal that does have a heart condition or blood pressure conditions may be allowed to use TPA, an veterinarian or other healthcare provider should be consulted before using TPA. Muscle spasms or neurological disorders may also be a disqualifying event for the use of TPA on an animal, but an animal's veterinarian or other healthcare provider should be consulted before using TPA.


Next the wound on the particular animal subject should be measured to determine the correct amount of TPA to be applied to the wound. Wound measurements may be taken various ways. In some instances, a technician or healthcare provider or induvial applying TPA may want to eyeball the wound and apply TPA based on simply looking at the wound. This method is not advised, especially for individuals applying TPA for the first time. Individuals with much experience measuring wounds and applying TPA may use this method because they have a sense of how much TPA should be applied. Inexperienced individuals may apply too much TPA. Applying too much TPA is not desired because TPA contains sulfur in it which in high enough amounts may actually irritate skin. Additionally, applying too much TPA may be uncomfortable to the animal. The animal may try and lick or get rid of the TPA.


One method of measuring a wound includes measuring the radius of the wound and determining the circumference of the wound. This may be accomplished via the formula C=2πR. In the event a wound is not a perfect circle, the wound should be treated as though it is a circle and the longest radius measured and the formula for circumference of a circle used. The centimeters of the wound should then be converted to milliliters (ml) of TPA and the appropriate amount of TPA used. For example, say a wound has a diameter of 4 cm, then the calculation would be (2)(4 cm wound radius)(3.14)=25.12 ml of TPA applied to the wound. From here the appropriate amount of TPA should be measured out before being applied to the wound.


Once the appropriate amount of TPA has been measured out, the wound site of the animal should be cleaned if muddy. Cleaning may consist of removing hairs, washing with warm water. Note the wound should be cleaned but not to such a degree where the animal's own oils are removed from the wound site. In the event the animal's own oils are removed from the site, the TPA may become less effective. A therapeutically effective amount of the animal's own oils should be left at the site. TPA may come in many forms. One possible form is a topical treatment for the treatment of animal wounds comprising 30%-33% by weight sulfur 30%-33% by weight Aloe vera or Aloe vera derivative 30-33% hydrocarbon polymer and at most 1% impurities. A more specific version would be 33 grams of sulfur, mixed with 33 grams of Aloe vera dust and 33 grams of petroleum jelly. A more specific version would be 33 grams of sulfur, mixed with 33 grams of Aloe vera gel and 33 grams of petroleum jelly. A more specific version would be 33 grams of sulfur, mixed with 16 grams of Aloe vera dust and 16 grams of Aloe vera gel and 33 grams of petroleum jelly.


Exact weight measurements may not be preferred because TPA when made industrially may be made in large batches. A range of appropriate weights may therefore be more important. A more specific version would be at least 33 grams of sulfur, mixed with at least 33 grams of Aloe vera gel and at least 33 grams of petroleum jelly. A more specific version would be at least 33 grams of sulfur, mixed with at least 16 grams of Aloe vera dust and at least 16 grams of Aloe vera gel and at least 33 grams of petroleum jelly. A more specific version would be between 30-35 grams of sulfur, mixed with at least 15-35 grams of Aloe vera dust and at least 15-35 grams of Aloe vera gel and at least 30-35 grams of petroleum jelly.


Other formulations may contain higher proportions of Aloe vera derivatives such as Veracylglucan and Acemannan. TPA production may follow a formula of at least 33 grams of sulfur, mixed with at least 33 grams of Aloe vera gel, that contains at least 10 mg of Veracylglucan and at least 33 grams of hydrogenated castor oil. Another formula may be Veracylglucan at least 33 grams of sulfur, mixed with at least 33 grams of Aloe vera gel, that contains at least 10 mg of Acemannan and at least 33 grams of hydrogenated castor oil.


Another The topical treatment of claim 1 wherein the Aloe vera derivative may be selected from a group consisting of Aloe vera extract, Veracylglucan (C56H82O51), Acemannan C66H101NO49; wherein the hydrocarbon polymer may be selected from the group consisting of petroleum jelly hydrogenated castor oil and beeswax.


It should be noted that when Aloe vera or Aloe vera derivative is used to make TPA, as in the preceding paragraphs, the Aloe vera or Aloe vera derivative may be obtained via the species within the Aloe family, such as Aloe vera, Aloe viridiflora, Aloe excelsa, Aloe thraskii, and Aloe namibensis. Additionally, impurities may be found in the species of Aloe vera listed above. The impurities may include enzymes such as the enzyme amylase. Impurities that are tolerable for TPA, and may actually be preferred include those outlined in SEQUENCE ID 1, SEQUENCE ID 2, SEQUENCE ID 3, SEQUENCE ID 4, SEQUENCE ID 5, or SEQUENCE ID 6. Sometimes, if sequences are used as impurities the impurities must be selected from the group of sequence IDs consisting of SEQUENCE ID 1, SEQUENCE ID 2, SEQUENCE ID 3, SEQUENCE ID 4, SEQUENCE ID 5, or SEQUENCE ID 6. In other instances, if sequences are used as impurities the impurities must be selected from the group consisting essentially of SEQUENCE ID 1, SEQUENCE ID 2, SEQUENCE ID 3, SEQUENCE ID 4, SEQUENCE ID 5, or SEQUENCE ID 6.


Another method of making TPA involves selecting a specimen of Aloe vera from an Aloe plant. de-dusting the Aloe vera specimen; washing the Aloe vera specimen in warm water, the warm water being exposed to the Aloe vera plant for at least five seconds; removing the rind from the Aloe vera specimen; washing the specimen a second time in warm water, the warm water being exposed to the Aloe vera plant for at least five seconds; inserting the specimen into a dehydrating machine for at least twelve hours; examining the Aloe vera specimen and verifying that the specimen is no more than 5% liquid by weight and modifying the specimen if there is more than 5% liquid by dry weight; grinding up the Aloe vera specimen until it is a fine powder of Aloe vera granules; mixing the Aloe vera granules with wet Aloe vera extract to create a dry-wet Aloe vera complex; mixing the dry-wet Aloe vera complex with sulfur until the mixture becomes a homogeneous mixture of sulfur and granules; combining the homogeneous mixture with petroleum jelly and homogenizing the homogeneous mixture with the petroleum jelly until the entire mixture becomes homogenous TPA with no more than 1% impurities. It is crucial the Aloe vera be mixed with the sulfur before the petroleum jelly, because if either the sulfur or Aloe vera is mixed with petroleum jelly first, the sulfur or petroleum jelly may begin to prematurely rehydrate and render the TPA less effective. One embodiment of TPA includes A topical treatment for the treatment of animal wounds comprising: 30%-33% by weight sulfur; 30%-33% by weight Aloe vera or Aloe vera derivative; 30-33% by weight hydrocarbon polymer; at most 5% by weight impurities.


De-dusting the plant is very important. Some technicians have made the mistake of washing the specimen without de-dusting. This is a problem because large granules of debris that may be present on the plant can actually scratch and scar the Aloe vera leaves. This may make the Aloe vera or Aloe vera derivative obtained from the plant much less desirable. If one were to wash without de-dusting the specimen may be damaged. Additionally the granule size of the Aloe vera powder are very important. In TPA granules should have a diameter of 30-40 μm.

Claims
  • 1. A topical treatment for the treatment of animal wounds comprising: 30%-33% sulfur;30%-33% Aloe vera or Aloe vera derivative;30-33% hydrocarbon polymer;At most 5% impurities.
  • 2. The topical treatment of claim 1 wherein the Aloe vera derivative may be selected from a group consisting of Aloe vera gel, Aloe vera powder, Aloe vera extract, Veracylglucan (C56H82O51), Acemannan C66H101NO49; wherein the hydrocarbon polymer may be selected from the group consisting of petroleum jelly hydrogenated castor oil and beeswax.
  • 3. The topical treatment of claim 1 wherein the sulfur comes in the form of S8.
  • 4. The topical treatment of claim 1 wherein the Aloe vera or Aloe vera derivative further comprises at least 30 micrograms of Veracylglucan, at least 10 micrograms of Acemannan, and 30 grams of Aloe vera plant extract.
  • 5. The topical treatment of claim 1 wherein the Aloe vera or Aloe vera derivative is obtained from a plant species within the Aloe family, the plant further comprising Aloe vera, Aloe viridiflora, Aloe excelsa, Aloe thraskii, and Aloe namibensis.
  • 6. The topical treatment of claim 1 wherein the impurities further comprise amylase selected from the group of sequence IDs consisting of SEQUENCE ID 1, SEQUENCE ID 2, SEQUENCE ID 3, SEQUENCE ID 4, SEQUENCE ID 5, or SEQUENCE ID 6.
  • 7. A method of applying a therapeutically effective amount of a topical treatment for an animal wound on an animal in need thereof comprising: selecting an individual animal from a group or herd of animals;consulting the animal's medical history and verifying that the animal does not have a disease affecting blood pressure, muscles, or neural cells;measuring the wound;dolling out an appropriate amount of TPA based on the wound measurement;cleaning the wound and shaving off hair feathers, scales, fur, hair, exoskeleton or other integument, but not disturbing the animal's natural oils or secretions;applying an effective amount of TPA to the wound site;reapplying TPA every day for at least two weeks;verifying that the wound has significantly decreased;reapplying TPA until the wound has significantly decreased.
  • 8. The method of claim 7 in wherein the TPA is a topical treatment for the treatment of animal wounds comprising: 30%-33% sulfur;30%-33% Aloe vera or Aloe vera derivative;30-33% hydrocarbon polymer;at most 5% impurities.
  • 9. The method of claim 7 wherein the TPA contains Aloe vera extract, Veracylglucan (C56H82O51), Acemannan C66H101NO49.
  • 10. The method of claim 7 wherein the TPA contains Aloe vera obtained from an Aloe plant of the species Aloe vera, Aloe viridiflora, Aloe excelsa, Aloe thraskii, and Aloe namibensis.
  • 11. A method of producing TPA comprising: selecting a specimen of Aloe vera from an Aloe plant; de-dusting the Aloe vera specimen;washing the Aloe vera specimen in warm water, the warm water being exposed to the Aloe vera plant for at least five seconds;removing the rind from the Aloe vera specimen;washing the specimen a second time in warm water, the warm water being exposed to the Aloe vera plant for at least five seconds;inserting the specimen into a dehydrating machine for at least twelve hours;examining the Aloe vera specimen and verifying that the specimen is no more than 5% liquid by weight and modifying the specimen if there is more than 5% liquid by dry weight;grinding up the Aloe vera specimen until it is a fine powder of Aloe vera granules;mixing the Aloe vera granules with wet Aloe vera extract to create a dry-wet Aloe vera complex;mixing the dry-wet Aloe vera complex with sulfur until the mixture becomes a homogeneous mixture of sulfur and granules;combining the homogeneous mixture with petroleum jelly and homogenizing the homogeneous mixture with the petroleum jelly until the entire mixture becomes homogenous TPA with no more than 1% impurities.
  • 12. The method of claim 11 wherein inserting the specimen into a dehydrating machine further comprises 135° F.-200° F. for six hours.
  • 13. The method of producing TPA in claim 11 wherein the sulfur is S8.
  • 14. The method of producing TPA in claim 11 wherein the Aloe vera specimen is configured to contain at least 30 mg of Veracylglucan (C56H82O51) and 30 mg of Acemannan C66H101NO49.
  • 15. The method of producing TPA in claim 11 wherein the granules have a diameter of 30-40 μm.
  • 16. The method of producing TPA in claim 11 wherein the fine powder Aloe vera granules constitute between 30%-40% of the final TPA; the sulfur constitutes 30-40% of the final TPA the petroleum jelly constitutes 30%-40% of the final TPA.
  • 17. The method of claim 11 in which the specimen of Aloe vera is selected from a plant within the species of Aloe vera, Aloe viridiflora, Aloe excelsa, Aloe thraskii, and Aloe namibensis.
  • 18. The method of claim 11 wherein the impurities further comprise amylase.
  • 19. The method of claim 11 wherein the impurities are selected from the group of sequence IDs consisting of SEQUENCE ID 1, SEQUENCE ID 2, SEQUENCE ID 3, SEQUENCE ID 4, SEQUENCE ID 5, or SEQUENCE ID 6.
  • 20. The method of claim 11 wherein the impurities consist essentially of SEQUENCE ID 6.
RELATED APPLICATIONS

This application is a continuation of U.S. patent application Ser. No. 17/092,150 filed Nov. 6, 2020 entitled, TOPICAL TREATMENT FOR ANIMALS, which claims priority to provisional application No. 62/931,543 filed on Nov. 6, 2019, all of which are incorporated herein by reference.

Provisional Applications (1)
Number Date Country
62931543 Nov 2019 US
Continuations (1)
Number Date Country
Parent 17092150 Nov 2020 US
Child 18319948 US